The D-Street experts also suggests buying One97 Communications at a target range of Rs 1,000-Rs 1,025 with a stoploss of Rs ...

India's pharma and healthcare sector saw 57 deals worth $1.30 billion in the quarter ending June. This reflects a drop ...

Pharma giants like Cipla, Glenmark, and Emcure are stepping into the booming skincare market, challenging beauty brands with ...

Bhavesh Shah, MD and Head of Investment Banking at Equirus, said M&A activity was around $25 billion over the past couple of ...

Both indices stayed in a narrow band through most of the day, with modest gains seen in the second half. The Sensex held ...

M&M, Wipro, Tech Mahindra, Nestle, SBI and Infosys led the gainers of Nifty 50 pack. Lack of fresh triggers, mixed global ...

How pain, trauma and politics silenced art criticism ART | EDDY FRANKEL | My friend winced. He’d asked for my thoughts on a ...

The Centre considers fixing retail prices for empagliflozin combinations as generic versions flood the market and lead to ...

Check Asston Pharmaceuticals Stock Price live NSE/BSE on financialexpress.com. Get Asston Pharmaceuticals today's stock price, 52-week high, 52-week low, Asston Pharmaceuticals quarterly results, ...

India’s big metros may still dominate headlines, but a quiet revolution is unfolding in smaller cities across the country.

Driven by a shift in business model, strong tailwinds in manufacturing, and aggressive capacity expansion, the three stocks have pulled off the extraordinary rally.

As infrastructure and investments pour in, Tier 2 and Tier 3 cities are fast emerging as new engines of employment and talent ...